4 6 6 4 3

论文已发表


注册即可获取德孚的最新动态



IF 收录期刊












更多详情 >>



停止接受任何荟萃分析文章 (Meta-analysis)

请注意:我们所有期刊已于 2019 年 4 月 1 日停止接受任何荟萃分析 (Meta-analysis)文章的提交。


会员计划

我们很高兴为机构提供一种切实的方法以支持开放获取并鼓励教师和研究人员通过开放获取模式尽可能广泛地传播他们的作品。

更多详情 >>

 

已发表论文

TPF 方案与华蟾素相结合可抑制人下咽和喉鳞状细胞癌细胞增殖并诱导其凋亡

 

Authors Shen X, Tao Y, Yang Y, Wang R, Fang J, Lian M

Received 27 August 2018

Accepted for publication 30 November 2018

Published 31 December 2018 Volume 2019:12 Pages 341—348

DOI https://doi.org/10.2147/OTT.S185428

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Justinn Cochran

Peer reviewer comments 3

Editor who approved publication: Dr Federico Perche

Background: Hypopharyngeal squamous cell carcinoma and laryngeal squamous cell carcinoma have a potential risk of metastasis and local recurrence. It is urgent to determine novel effective therapy.
Methods: UMSCC5 and FADU cells were treated with TPF regimen (a mixture comprising paclitaxel, cisplatin, and 5-fluorouracil), cinobufotalin, and combination. Cell counting kit-8 (CCK-8), clone formation assays, and flow cytometry were performed to investigate whether combination of cinobufotalin and TPF can exhibit synergistic effects in reducing tumor growth.
Results: CCK-8 assay and IC50 analysis showed that the TPF and cinobufotalin could suppress viability of UMSCC5 and FADU cells, implying the strong antitumor effect. The synergism between TPF and cinobufotalin was further verified by the CCK-8 and clone formation assays showing the TPF- and cinobufotalin-suppressed cell proliferation synergistically. Notably, flow cytometry showed that the combination also promoted apoptosis synergistically.
Conclusion: TPF regimen combining cinobufotalin suppressed proliferation and promoted apoptosis synergistically in hypopharyngeal squamous cell carcinoma and laryngeal squamous cell carcinoma cells.
Keywords: TPF regimen, cinobufotalin, hypopharyngeal and laryngeal squamous cell carcinoma, proliferation, apoptosis




Figure 2 TPF and cinobufotalin suppress the viability of UMSCC5 and FADU cells time-dependently.